This topic examines GenAI platform choices for large healthcare organizations — contrasting productivity-integrated assistants like Microsoft 365 Copilot with enterprise live-intelligence offerings such as Orange Business Live Intelligence — and how those choices map to automation, data platforms, compliance, and security governance needs. Healthcare deployments increasingly demand low-latency access to patient data, strict data residency and auditability, and tight integration with electronic health records (EHRs) and clinical workflows. Microsoft 365 Copilot represents a productivity-first approach, embedding generative capabilities across Word, Excel, Teams, Outlook and SharePoint to accelerate documentation, care coordination, and administrative automation. By contrast, Orange Business Live Intelligence (Orange Business Services’ enterprise GenAI offering) targets operational, real-time insights often tied to connectivity, edge and domain-specific telemetry for live operational decisioning. Complementary technologies matter: model providers and multimodal stacks (Google Gemini, Anthropic’s Claude, Mistral) supply foundation models; IBM watsonx Assistant enables enterprise virtual agents and no-code assistant orchestration; MindStudio and LangChain provide no-code/low-code and developer frameworks for building, testing and governing agents. For healthcare buyers in 2026 the critical considerations are data platform architecture (secure ingestion, de-identification, traceable lineage), regulatory compliance (HIPAA, GDPR, local health data rules), and AI security/governance (model evaluation, access controls, monitoring). The practical trade-offs are integration depth and clinician workflow fit versus bespoke operational intelligence and edge-enabled use cases. Successful deployments lean on robust data governance, hybrid deployment options, validated models, and vendor interoperability to meet both clinical safety and enterprise risk requirements.